George Tidmarsh: FDA Resignation and Lawsuit
November 5, 2025
Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit
2 min read
False
Advertisement
Industry News
Securing Europe’s Antibiotic Supply: A More Functional Future
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
Texas Takes on Tylenol
October 31, 2025
Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.
2 min read
Summarizing the Big Events in the Small Molecules Field
October 30, 2025
October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.
4 min read
CPHI 2025: AI, the Pharma Workforce, and Reshaping Investment
October 29, 2025
Day 3 of our special show coverage of CPHI Frankfurt
2 min read
This Week’s Biopharma News: Novo Nordisk Board Shakeup
October 28, 2025
This week’s news roundup reports on the boardroom reshuffle at Novo Nordisk, Novartis’ neuromuscular expansion, GSK’s Global Fund pledge and more.
4 min read
Get Ready for Day 2 of CPHI 2025: Sustainability Power Hour
October 28, 2025
We select highlights from the show’s agenda
3 min read
Get Ready for CPHI: Off-Patent Semaglutide and Sustainability in a Shifting World
October 27, 2025
It’s showtime in Frankfurt – with around 62,000 attendees expected.
4 min read
The Cell & Gene Circuit: Keeping Up With Advancing Therapies and Technologies
October 22, 2025
Cell and gene therapy is advancing faster than ever, powered by breakthroughs in AI, automation, and CRISPR technology. But as some companies double down and others step back, the race to deliver real-world impact is intensifying.
4 min read
This Week’s Biopharma News: Collaborating for Pandemic Preparedness
October 21, 2025
Our latest news roundup reports on FDA approval for oral semaglutide, suspension of a Pfizer medicine in Europe, a mAb for preventing malaria, and more
4 min read
